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Abstract
AIM: To compare the binding of cholecystokinin (CCK)-8 
to CCK receptors in sling and clasp fibers of the human 
lower esophageal sphincter.
METHODS: Esophageal sling and clasp fibers were 
isolated from eight esophagectomy specimens, re-
sected for squamous cell carcinoma in the upper two 
thirds of the esophagus, which had been maintained 
in oxygenated Kreb’s solution. Western blot was used 
to measure CCK-A and CCK-B receptor subtypes in the 
two muscles. A radioligand binding assay was used 
to determine the binding parameters of 3H-CCK-8S to 
the CCK receptor subtypes. The specificity of binding 
was determined by the addition of proglumide, which 
blocks the binding of CCK to both receptor subtypes.
RESULTS: There was no significant difference between 
the sling and clasp fibers of the human lower esopha-
geal sphincter in the amount of CCK-A [integrated 
optical density (IOD) value: 22.65 ± 0.642 vs  22.328 
± 1.042, P  = 0.806] or CCK-B receptor protein (IOD 
value: 13.20 ± 0.423 vs  12.45 ± 0.294, P  = 0.224) as 
measured by Western blot. The maximum binding of 
radio-labeled CCK-8S was higher in the sling fibers than 
in the clasp fibers (595.75 ± 3.231 cpm vs  500.000 
± 10.087 cpm, P  < 0.001) and dissociation constant 
was lower (Kd: 1.437 ± 0.024 nmol/L vs  1.671 ± 0.024 
nmol/L, P  < 0.001). The IC50 of the receptor specific 
antagonists were lower for the CCK-A receptors than 
for the CCK-B (P  < 0.01).
CONCLUSION: CCK binding modulates the contractile 
function of the lower esophageal sphincter through dif-
ferential binding to the CCK-A receptor on the sling and 
clasp fibers.
© 2014 Baishideng Publishing Group Inc. All rights reserved.
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Core tip: We isolated the sling and clasp muscles which 
help form the human lower esophageal sphincter. The 
expression of cholecystokinin (CCK)-A and CCK-B re-
ceptors was measured in the two muscles. The binding 
of 3H-CCK-8S to the CCK receptors was studied to de-
termine the binding characteristics of the hormone to 
the receptor subtypes. It is concluded that the CCK-A 
receptor probably plays a more important role than the 
CCK-B receptor in mediating the contractile function of 
lower esophageal sphincter, through a combination of 
more receptors and a stronger binding affinity.
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INTRODUCTION
The lower esophageal sphincter (LES) is the incrassate 
muscle bundle located at the esophagogastric junction, 
and includes the sling fibers from the greater curvature 
and clasp fibers from the lesser curvature of  the stom-
ach[1]. The LES can open to allow liquids or solids to 
enter the stomach, or to permit vomiting or belching. 
At other times the basal tone of  the LES is intended 
to prevent abnormal reflux of  gastric contents into the 
esophagus[2]. The regulation of  the LES is complex, 
involving interplay between the nervous and hormonal 
systems, as well as local myogenic influences[3,4]. In par-
ticular, gastrointestinal peptide hormones play important 
roles in its regulation[5,6].
The cholecystokinins (CCK) are a family of  peptide 
hormones which have important roles in regulating gas-
trointestinal motility and the delivery of  nutrients to the 
small intestine[7-10]. The individual members are identified 
by the number of  amino acids in the hormone follow-
ing post-translational modification of  the CCK gene 
product, preprocholecystokinin (e.g., CCK-58, CCK-8). 
The receptors for CCK are divided into two subtypes, 
CCK-A and CCK-B, based on their affinities to CCK 
analogues, gastrin and specific antagonists. Gastrin and 
CCK are similar in structure, and both bind to CCK-B 
receptors. We have previously shown that human sling 
and clasp fibers contract in response to both gastrin and 
CCK-8, but the sling fibers have stronger contractions 
than the clasp fibers[6].
Structural and functional abnormalities of  the LES 
may result in esophageal diseases[11,12]. An incompetent 
LES permits gastro-esophageal reflux, which damages 
the esophageal epithelial lining and may lead to com-
plications such as esophagitis, Barrett’s esophagus or 
cancer[13,14]. Currently, antireflux surgery, typically Nis-
sen fundoplication, is the mainstay treatment to prevent 
reflux, but it is invasive and has a number of  potential 
side-effects. A better understanding of  the physiology 
of  the LES may lead to medical interventions to prevent 
or reduce reflux, avoiding the need for surgery. In this 
study we investigated if  the differential response of  sling 
and clasp fibers to CKK-8 correlates with differential 




Specimens of  the esophagogastric junction were ob-
tained from 5 men and 3 women (mean age 53 years, 
range 45-75 years) who underwent esophagectomy for 
squamous cell carcinoma in the upper two-thirds of  the 
esophagus. Patients with heartburn symptoms or motil-
ity disorders, such as achalasia of  the esophagus or der-
matosclerosis, were excluded from the study. Immedi-
ately after removal from the patient the esophagogastric 
junction tissue was placed in oxygenated Kreb’s solution 
and transported to the laboratory. Frozen section histol-
ogy was performed to confirm absence of  tumor in the 
specimens. The sling and clasp fibers (Figure 1) were 
separated as described previously[6]. The experimental 
protocol was approved by the Ethics Committee of  the 
Fourth Hospital, Hebei Medical University.
Western blot
Membrane proteins were isolated using the Eukaryotic 
Membrane Protein Extraction kit (Pierce, Rockford, IL, 
United States), following the manufacturer’s instructions. 
The CCK-A and CCK-B receptors in the membrane 
protein preparation were detected by Western blot as 
previously described[15]. A goat polyclonal antibody to 
human CCK-A receptor (1:400 dilution) and a goat poly-
clonal antibody to human CCK-B receptor (Santa Cruz, 
United States) were each used at a dilution of  1:400. The 
secondary antibody was a donkey anti-goat IgG conju-
gated to peroxidase, used at a 1:2000 dilution and devel-
oped with DAB. The integrated optical density (IOD) of  
each band was determined using the Gel-Pro analyzer 
software package (Media Cybernetics, United States).
Binding studies
The binding studies were carried out as described by Sal-
vatore et al[16]. The membrane protein isolate was incu-
bated, at a final concentration of  0.15 mg/mL with serial 
dilutions of  3H-CCK-8S (Sigma, United States), ranging 
from 6.4 nmol/L to 0.05 nmol/L in a total volume of  
200 μL for 10 h at 4 ℃ with shaking every 30 min. The 
specificity of  binding was determined by the addition 
of  5 μmol/L proglumide, which blocks the binding 
of  CCK to both receptor subtypes. Bound ligand was 
isolated by filtration under vacuum on Whatman GF/B 
filters which were then washed three times with ice-cold 
HEPES buffer (130 mmol/L NaCl, 5 mmol/L MgCl2 
and 10 mmol/L HEPES, pH 7.4). Bound radioactivity 
was measured by liquid scintillation counting (Model 
LS 6500, Beckman Instruments, Fullerton, CA, United 
States). Nonspecific binding, defined as the binding of  
radiolabelled ligand in the presence of  10 mmol/L CCK, 
was subtracted from the total binding measured in each 
assay. Competitive inhibition was determined using 7.5 
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Figure 1  Arrangement of the sling and clasp muscles in the human gas-
troesophageal junction viewed from the distal luminal aspect after resec-
tion of the submucosa.
Table 1  Expression of cholecystokinin-A and cholecystoki-
nin-B receptors in human sling and clasp muscles
nmol/L 3H-CCK-8S with CR1409 as an antagonist to 
the CCK-A receptor or CR2945 to the CCK-B receptor 
(Sigma, United States). Data were analyzed and competi-
tive curves constructed from the mean of  triplicate mea-
surements. The dissociation constant of  the radioligand 
receptor complex (Kd) and the maximum binding value 
(Bmax) were calculated using GraphPad Prism version 4.0 
(GraphPad Software Inc., San Diego, CA, United States). 
The inhibitory binding constant Ki was calculated from 
the IC50 according to the Cheng-Prusoff  equation, Ki = 
IC50/(l + L/Kd), where L is the concentration of  the ra-
dioligand, IC50 is the concentration of  drug causing 50% 
inhibition of  the specific radioligand binding, and Kd is 
dissociation constant[17].
Statistical analysis
Data are expressed as mean ± SD, and groups were 
compared by the paired Student’s t test using the SPSS 
statistical program. Differences were considered statisti-
cally significant when P < 0.05.
RESULTS
Receptor expression
Both CCK-A and CCK-B receptors were measured in 
the membrane protein extract of  the sling and the clasp 
muscle fibers by Western blot (Figure 2). The results in 
Table 1 show that the IOD for the beta-actin loading 
control did not differ between the fibers. There were no 
significant differences between the sling and clasp fibers 
in the IOD for the CCK-A (t = 0.263, P = 0.806) or the 
CCK-B (t = 1.439, P = 0.224) receptors.
Binding studies
The binding of  3H-CCK-8S to the CCK receptor was 
specific in both the sling and clasp fibers. A typical satu-
ration isotherm plot for the binding of  3H-CCK-8S to 
human cell membrane protein extract is shown in Figure 
3. The mean Bmax and Kd values for all eight sling and 
clasp muscle preparations analysed (clasp fibers: 500.00 
± 10.09 vs 1.671 ± 0.024; sling fibers: 595.75 ± 3.23 vs 
1.437 ± 0.024; t: 9.040 vs 6.898) differed significantly 
between the sling and the clasp fibers (each P < 0.001). 
The results in Figure 4 show the competitive inhibi-
tion curves of  the specific CCK-A receptor antagonist, 
CR1409, and the specific CCK-B receptor antagonist, 
CR2945, for the binding of  3H-CCK-8S to the mem-
brane protein extract from the sling and clasp fibers. 
The mean IC50 values for CR1409 and CR2945 for all 
eight sling and clasp muscle preparations analysed are 
shown in Table 2. There were no significant differences 
between the sling and clasp fibers in the IC50 for CR1409 
(t = 1.72, P = 0.161) or CR2945 (t = 1.93, P = 0.126). In 
both the sling and clasp fibers the IC50 for CR1409 was 
significantly higher than that for CR2945 (P = 0.001 and 
P < 0.001 respectively). The pKi values were also greater 
for CR1409 than for CR2495 in both the sling and clasp 
fibers (Table 2) (each P < 0.001).
DISCUSSION
The gastrointestinal hormone CCK plays an important 
role in the regulation of  gastrointestinal motility. We 
have previously shown that the sling and clasp fibers, 
which contribute to the tone of  the LES, contract in re-





Figure 2  Western blots of the cholecystokinin-A and cholecystokinin-B 
receptors in the human sling and clasp muscles. CCK: Cholecystokinin.
n CCK-AR CCK-BR
Clasp fibers 8 22.328 ± 1.042 12.45 ± 0.294
Sling fibers 8   22.65 ± 0.642 13.20 ± 0.423
t 0.263 1.439
P value 0.806 0.224
The data are integrated optical densities from Western blots and are ex-
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Figure 3  Representative saturation isotherms of the binding of 3H-cho-
lecystokinin-8S to membrane proteins isolated from the human sling (A) 
and clasp (B) fibers. CCK: Cholecystokinin.
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Table 2  IC50 values and pKi values
sponse to CCK. The strength of  the response differs be-
tween these fibers, with the sling fibers contracting more 
strongly than the clasp fibers[6]. We report here that the 
binding of  CCK-8 to the CCK receptor subtypes differs 
between these two types of  fibers, which may provide 
an explanation for the difference in their response to the 
hormone.
The expression and distribution of  the two CCK re-
ceptor subtypes, CCK-A and CCK-B, vary between tis-
sues and organs, and within different parts of  the same 
organ, within a species[15]. CR1409 is a selective antago-
nist of  the CCK-A receptor[18], with concentration de-
pendent inhibitory effects on CCK-8 mediated respons-
es in vivo, such as satiety or contraction of  the smooth 
muscle of  the ileum or gallbladder[19]. CR-2945 is a po-
tent, selective and reversible non-peptide antagonist of  
CCK-B receptor. It is a candidate new generation, non-
sedative anxiolytic, as well being considered a treatment 
for acid-related dyspeptic symptoms, where visceral mo-
tility and acid exposure play a role[20]. We found that the 
IC50 for CR1409 was less than that for CR2945 in both 
the sling and clasp muscles, with the pKi for CR1409 
greater than that for CR2945. There were no significant 
differences in the IC50 of  CR1409 and CR2945 between 
the clasp fibers and sling fibers, implying that there were 
no differences in the affinity of  each antagonist to its 
receptor between the two fibers. The difference in the 
Bmax for the binding of  the radiolabelled CCK-8S be-
tween the sling fibers and clasp fibers suggest that there 
are more CCK receptors in the sling fibers than in the 
clasp fibers. Our results are consistent with the ability of  
CCK to induce contraction of  the sling and clasp fibers 
by binding to both receptor subtypes, with induction 
of  stronger contractions in the sling fibers because of  
higher binding to the CCK-A receptor.
A number of  studies show that CCK can reduce LES 
pressure, most commonly following a meal, when plasma 
levels of  the hormone are significantly elevated. Boulant 
et al[21] found in dogs that CCK infusion increased tran-
sient LES relaxations (TLESRs), and that a CCK-A re-
ceptor antagonist (but not a CCK-B receptor antagonist) 
prevented this increase, without affecting the basic tone 
of  the LES. Ledeboer et al[22] demonstrated in humans 
that the TLESRs following a fat meal, which are CCK 
mediated, are reduced by the CCK-A receptor antago-
nist loxiglumide. Masclee et al[23] reported that ingestion 
of  cholestyramine in humans resulted in a reduction of  
LES pressure, again an effect which could be abolished 
by loxiglumide, and similar findings following infusion 
of  a triglyceride meal were reported by Trudgill et al[11]. 
The postprandial reduction in LES pressure is complex, 
involving at least CCK and nitric oxide[12,22,24]. Salapatek 
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Figure 4  Representative competitive inhibition curves of the binding of 3H- cholecystokinin-8S to membrane proteins isolated from the human sling (A) 
and clasp (B) fibers. The antagonists used were CR-1409 [selective for cholecystokinin (CCK)-A receptors] and CR-2945 (CCK-B receptors). Binding is expressed 
as the percentage of radioactivity specifically bound in the absence of antagonists.
n CR1409 CR2945 t P  value
IC50 values
Clasp fibers 8 3.165 ± 0.187 9.583 ± 0.501 11.99 < 0.001
Sling fibers 8 2.798 ± 0.104 8.147 ± 0.551   9.53    0.001
t 1.72 1.93
P value   0.161   0.126
pKi values
Clasp fibers 8 8.476 ± 0.065 8.018 ± 0.028 12.69    0.001
Sling fibers 8 8.556 ± 0.022 8.090 ± 0.042 11.73    0.001
t   1.653   2.754
P value   0.156   0.058
The IC50 values and pKi values for the CCK-A receptor antagonist CR1409 and the CCK-B receptor antagonist CR2945 in human sling and clasp fibers (× 10-9 
mol/L; mean ± SD).
-12.0 -12.0 -11   -10    -9     -8     -7     -6     -5
Liu JF et al . CCK receptors in the human LES
et al[25] found in cats that CCK induced LES contraction 
through a preganglionic cholinergic mechanism involv-
ing a nicotinic synapse, but induction of  relaxation oc-
curred predominantly at a postganglionic site involving 
adrenergic modulation. Based on these experiments it 
was proposed that there is animal-to-animal variability 
in the balance of  excitatory and inhibitory mechanisms 
to the LES, which determines the effect of  a mediator 
which is capable of  activating both mechanisms[25].
The most likely explanation for the difference in ac-
tion of  CCK described in these reports and our study is 
that we studied the effect of  the hormone on contrac-
tion of  the isolated sling and clasp fibers in vitro, whereas 
in the other studies the LES pressure was measured in 
vivo[25]. The location of  a high pressure zone at the gas-
troesophageal junction and the asymmetric distribution 
of  the pressure, as measured by esophageal manometry, 
are in concordance with the position and arrangement 
of  the two bundles of  fibers[26]. Thus, while it is clear 
that the sling and clasp fibers contribute to the genera-
tion of  the LES pressure, they are not the only muscles 
involved. Additionally, in vitro studies permit the mea-
surement of  effects due to CCK alone, whereas with in 
vivo studies it is difficult to control for all the variables 
which may impact on a function as complex as that 
which regulates LES pressure.
In conclusion, we found no difference in the amount 
of  CCK-A or CCK-B receptors between human sling 
and clasp fibers, as measured by Western blot, but the 
sling fibers bound more radiolabelled CCK-8S than the 
clasp fibers. Our binding and inhibition data are consis-
tent with the CCK-A receptor playing an important role 
in mediating the contractile function of  the LES, acting 
through differential effects on the sling and clasp fibers.
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